2018年欧洲癌症死亡率预测:聚焦结直肠癌
该研究基于世界卫生组织死亡认证数据和Eurostat人口数据,采用Joinpoint回归模型预测欧盟及六个主要国家2018年癌症死亡率。结果显示欧盟总癌症死亡率男性下降10.3%、女性下降5.0%,结直肠癌死亡率男女分别下降6.7%和7.5%,但女性肺癌和胰腺癌呈不利趋势。
要点
- 欧盟2018年男性总癌症死亡率预测下降10.3%至128.9/10万,女性下降5.0%至83.6/10万。
- 结直肠癌死亡率男女分别下降6.7%和7.5%,各年龄组均下降,归因于治疗改善和50岁以上组织性筛查。
核心结论
- 预测欧盟及其主要国家至2018年主要癌症部位死亡率持续下降,但女性肺癌和胰腺癌例外。
研究设计与样本
- 基于世界卫生组织死亡认证数据库和Eurostat人口数据,采用Joinpoint回归模型预测2018年欧盟及法国、德国、意大利、波兰、西班牙、英国癌症死亡数和年龄标准化率。
主要发现
- 欧盟2012至2018年男性总癌症死亡率预测下降10.3%至128.9/10万,女性下降5.0%至83.6/10万。
- 结直肠癌预测死亡率男性为15.8/10万(下降6.7%),女性为9.2/10万(下降7.5%),所有年龄组均预计下降。
- 胰腺癌男性稳定,女性自2012年上升2.8%;卵巢、子宫和膀胱癌死亡率预计进一步下降。
关键数值与推荐
- 2018年欧盟男性总癌症预测死亡率128.9/10万,女性83.6/10万。
- 2018年结直肠癌预测死亡率男性15.8/10万(-6.7%),女性9.2/10万(-7.5%)。
临床怎么用
- 结直肠癌死亡率下降趋势支持治疗改进和50岁以上组织性筛查的积极作用。
- 女性肺癌死亡率上升提示需加强女性吸烟防控和肺癌早期筛查。
- 胰腺癌女性死亡率上升需关注其危险因素和早期诊断策略。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We projected cancer mortality statistics for 2018 for the European Union (EU) and its six more populous countries, using the most recent available data. We focused on colorectal cancer. MATERIALS AND METHODS: We obtained cancer death certification data from stomach, colorectum, pancreas, lung, breast, uterus, ovary, prostate, bladder, leukaemia, and total cancers from the World Health Organisation database and projected population data from Eurostat. We derived figures for France, Germany, Italy, Poland, Spain, the UK, and the EU in 1970-2012. We predicted death numbers by age group and age-standardized (world population) rates for 2018 through joinpoint regression models. RESULTS: EU total cancer mortality rates are predicted to decline by 10.3% in men between 2012 and 2018, reaching a predicted rate of 128.9/100 000, and by 5.0% in women with a rate of 83.6. The predicted total number of cancer deaths is 1 382 000 when compared with 1 333 362 in 2012 (+3.6%). We confirmed a further fall in male lung cancer, but an unfavourable trend in females, with a rate of 14.7/100 000 for 2018 (13.9 in 2012, +5.8%) and 94 500 expected deaths, higher than the rate of 13.7 and 92 700 deaths from breast cancer. Colorectal cancer predicted rates are 15.8/100 000 men (-6.7%) and 9.2 in women (-7.5%); declines are expected in all age groups. Pancreatic cancer is stable in men, but in women it rose +2.8% since 2012. Ovarian, uterine and bladder cancer rates are predicted to decline further. In 2018 alone, about 392 300 cancer deaths were avoided compared with peak rates in the late 1980s. CONCLUSION: We predicted continuing falls in mortality rates from major cancer sites in the EU and its major countries to 2018. Exceptions are pancreatic cancer and lung cancer in women. Improved treatment and-above age 50 years-organized screening may account for recent favourable colorectal cancer trends.
引用
- Malvezzi M, Carioli G, Bertuccio P, et al. European cancer mortality predictions for the year 2018 with focus on colorectal cancer. Ann Oncol. 2018. PMID: 29562308. doi:10.1093/annonc/mdy033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。